First Leadless Pacemaker-Defibrillator System Is Put to the Test in New Global Trial
Device integrates wireless communication between leadless pacing and ICD therapy
Related Articles
Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood
Early communication between oncologists and ophthalmologist warranted
Case Study: EBV-Associated Primary CNS Lymphoma in a Patient on Long-Term Mycophenolate Mofetil
First reported case in a patient with diffuse cutaneous systemic sclerosis
Considerations When Evaluating Pulmonary Cysts
A Cleveland Clinic pulmonologist highlights several factors to be aware of when treating patients
Cardiac MR-Enriched Phenomapping Shows Potential to Improve Therapeutic Selection in ICM
Cardiac MR-based phenomapping represents a promising new approach to patient selection for procedural intervention for ischemic cardiomyopathy Cardiac MR-based phenomapping may be a key to…
Lung Cancer Study Links Preoperative Factors With Spread Through Air Spaces
A study has identified preop characteristics predictive of spread through air spaces (STAS) in lung cancer, promising guidance for surgical decisions.
TRAVERSE Substudy Links Testosterone Therapy to Increased Fracture Risk in Older Men With Hypogonadism
A surprising outcome has emerged from the TRAVERSE study of testosterone replacement therapy in men with hypogonadism: an increased risk of fractures relative to placebo.
Unique “Neighborhood” Addresses Needs of Patients With Sickle Cell Disease
Novel program provides lifelong support to patients with sickle cell disease using specialized, multidisciplinary care coordination.
Motion-Tracking Brillouin Microscopy Detects Keratoconus Before It’s Clinically Evident
For the first time, researchers show that Brillouin microscopy can detect keratoconus in its early stages, before it becomes clinically evident.
Vertebral Body Tethering Is a Promising Alternative to Spinal Fusion Surgery
Cleveland Clinic pediatric spine surgeon shares his insights
Dietary Supplements Don’t Stack Up to Low-Dose Statin Therapy for LDL-C Reduction
Randomized controlled study undercuts unsubstantiated ‘heart health’ claims